nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—Isoetarine—asthma	0.267	0.569	CrCtD
L-DOPA—Isoprenaline—asthma	0.202	0.431	CrCtD
L-DOPA—Isoetarine—Orciprenaline—asthma	0.019	0.056	CrCrCtD
L-DOPA—Masoprocol—Isoprenaline—asthma	0.0173	0.0509	CrCrCtD
L-DOPA—Methyldopa—Isoetarine—asthma	0.0148	0.0436	CrCrCtD
L-DOPA—Norepinephrine—Isoetarine—asthma	0.0148	0.0436	CrCrCtD
L-DOPA—Droxidopa—Isoetarine—asthma	0.0148	0.0436	CrCrCtD
L-DOPA—Dopamine—Isoetarine—asthma	0.0148	0.0436	CrCrCtD
L-DOPA—Epinephrine—Pirbuterol—asthma	0.0143	0.042	CrCrCtD
L-DOPA—Levonordefrin—Isoetarine—asthma	0.0139	0.0409	CrCrCtD
L-DOPA—Epinephrine—Orciprenaline—asthma	0.0134	0.0395	CrCrCtD
L-DOPA—Carbidopa—Isoprenaline—asthma	0.013	0.0382	CrCrCtD
L-DOPA—Isoetarine—Isoprenaline—asthma	0.012	0.0354	CrCrCtD
L-DOPA—Epinephrine—Terbutaline—asthma	0.0116	0.0343	CrCrCtD
L-DOPA—Norepinephrine—Isoprenaline—asthma	0.0112	0.033	CrCrCtD
L-DOPA—Methyldopa—Isoprenaline—asthma	0.0112	0.033	CrCrCtD
L-DOPA—Dopamine—Isoprenaline—asthma	0.0112	0.033	CrCrCtD
L-DOPA—Droxidopa—Isoprenaline—asthma	0.0112	0.033	CrCrCtD
L-DOPA—Epinephrine—Isoetarine—asthma	0.0112	0.033	CrCrCtD
L-DOPA—Isoprenaline—Orciprenaline—asthma	0.0109	0.0322	CrCrCtD
L-DOPA—Isoetarine—Salbutamol—asthma	0.0109	0.0322	CrCrCtD
L-DOPA—Levonordefrin—Isoprenaline—asthma	0.0105	0.031	CrCrCtD
L-DOPA—Norepinephrine—Salbutamol—asthma	0.0102	0.03	CrCrCtD
L-DOPA—Levonordefrin—Salbutamol—asthma	0.00956	0.0281	CrCrCtD
L-DOPA—Isoprenaline—Terbutaline—asthma	0.00947	0.0279	CrCrCtD
L-DOPA—CYP2D6—Ciclesonide—asthma	0.0093	0.17	CbGbCtD
L-DOPA—Isoprenaline—Isoetarine—asthma	0.00912	0.0268	CrCrCtD
L-DOPA—Epinephrine—Isoprenaline—asthma	0.0085	0.025	CrCrCtD
L-DOPA—Isoprenaline—Formoterol—asthma	0.00828	0.0244	CrCrCtD
L-DOPA—Isoprenaline—Arformoterol—asthma	0.00828	0.0244	CrCrCtD
L-DOPA—Epinephrine—Salbutamol—asthma	0.00771	0.0227	CrCrCtD
L-DOPA—CYP2D6—Ipratropium bromide—asthma	0.00771	0.141	CbGbCtD
L-DOPA—CYP2D6—Zafirlukast—asthma	0.00679	0.124	CbGbCtD
L-DOPA—CYP2D6—Formoterol—asthma	0.00656	0.12	CbGbCtD
L-DOPA—CYP2D6—Arformoterol—asthma	0.00656	0.12	CbGbCtD
L-DOPA—Isoprenaline—Salbutamol—asthma	0.00628	0.0185	CrCrCtD
L-DOPA—CYP2D6—Tiotropium—asthma	0.00584	0.107	CbGbCtD
L-DOPA—CYP2D6—Theophylline—asthma	0.00524	0.0958	CbGbCtD
L-DOPA—CYP2D6—Loratadine—asthma	0.00497	0.0909	CbGbCtD
L-DOPA—CYP2D6—Dexamethasone—asthma	0.00172	0.0314	CbGbCtD
L-DOPA—PSIP1—bronchus—asthma	0.000962	0.0838	CbGeAlD
L-DOPA—PSIP1—cardiovascular system—asthma	0.000896	0.078	CbGeAlD
L-DOPA—Masoprocol—LTB4R—asthma	0.000886	0.37	CrCbGaD
L-DOPA—PSIP1—trachea—asthma	0.000864	0.0753	CbGeAlD
L-DOPA—SLC7A5—Procaterol—Indacaterol—asthma	0.000777	0.453	CbGdCrCtD
L-DOPA—PSIP1—adrenal gland—asthma	0.000708	0.0617	CbGeAlD
L-DOPA—DDC—respiratory system—asthma	0.000667	0.0581	CbGeAlD
L-DOPA—PSIP1—lung—asthma	0.000621	0.0541	CbGeAlD
L-DOPA—SLC7A5—respiratory system—asthma	0.000597	0.052	CbGeAlD
L-DOPA—Mimosine—CCL2—asthma	0.000521	0.218	CrCbGaD
L-DOPA—SLC7A5—epithelium—asthma	0.000499	0.0435	CbGeAlD
L-DOPA—SLC7A5—bronchus—asthma	0.000491	0.0428	CbGeAlD
L-DOPA—SLC7A5—smooth muscle tissue—asthma	0.000481	0.0419	CbGeAlD
L-DOPA—SLC7A8—adrenal gland—asthma	0.000467	0.0407	CbGeAlD
L-DOPA—SLC7A5—cardiovascular system—asthma	0.000457	0.0398	CbGeAlD
L-DOPA—SLC7A5—trachea—asthma	0.000441	0.0384	CbGeAlD
L-DOPA—SLC15A1—epithelium—asthma	0.000414	0.0361	CbGeAlD
L-DOPA—SLC7A8—lung—asthma	0.000409	0.0356	CbGeAlD
L-DOPA—DDC—adrenal gland—asthma	0.000404	0.0352	CbGeAlD
L-DOPA—SLC16A10—epithelium—asthma	0.000382	0.0333	CbGeAlD
L-DOPA—SLC7A5—adrenal gland—asthma	0.000362	0.0315	CbGeAlD
L-DOPA—DDC—lung—asthma	0.000354	0.0308	CbGeAlD
L-DOPA—SLC7A5—lung—asthma	0.000317	0.0276	CbGeAlD
L-DOPA—SLC7A5—Procaterol—Isoetarine—asthma	0.000298	0.174	CbGdCrCtD
L-DOPA—DRD2—respiratory system—asthma	0.000289	0.0252	CbGeAlD
L-DOPA—SLC16A10—lung—asthma	0.000243	0.0212	CbGeAlD
L-DOPA—Masoprocol—ALOX5—asthma	0.000205	0.0855	CrCbGaD
L-DOPA—Aminosalicylic Acid—ALOX5—asthma	0.00019	0.0795	CrCbGaD
L-DOPA—DRD2—lung—asthma	0.000154	0.0134	CbGeAlD
L-DOPA—Mesalazine—ALOX5—asthma	0.000149	0.0624	CrCbGaD
L-DOPA—Isoetarine—ADRB2—asthma	0.000111	0.0464	CrCbGaD
L-DOPA—SLC7A5—Desoximetasone—Fluticasone furoate—asthma	9.14e-05	0.0533	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Fluticasone Propionate—asthma	8.53e-05	0.0497	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Beclomethasone—asthma	6.27e-05	0.0365	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Budesonide—asthma	6.01e-05	0.035	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Flunisolide—asthma	5.93e-05	0.0346	CbGdCrCtD
L-DOPA—Droxidopa—ADRB2—asthma	5.07e-05	0.0212	CrCbGaD
L-DOPA—SLC7A5—Desoximetasone—Mometasone—asthma	4.86e-05	0.0283	CbGdCrCtD
L-DOPA—Isoprenaline—ADRB2—asthma	4.61e-05	0.0193	CrCbGaD
L-DOPA—Aminosalicylic Acid—PTGS2—asthma	4.6e-05	0.0192	CrCbGaD
L-DOPA—Epinephrine—TNF—asthma	4.37e-05	0.0183	CrCbGaD
L-DOPA—Norepinephrine—ADRB2—asthma	4.27e-05	0.0178	CrCbGaD
L-DOPA—Epinephrine—ADRB2—asthma	3.87e-05	0.0162	CrCbGaD
L-DOPA—Mesalazine—PTGS2—asthma	3.61e-05	0.0151	CrCbGaD
L-DOPA—PSIP1—Levonorgestrel—Hydrocortisone—asthma	3.56e-05	0.0207	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Hydrocortisone—asthma	3.08e-05	0.0179	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Methylprednisolone—asthma	2.9e-05	0.0169	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Betamethasone—asthma	2.86e-05	0.0167	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Dexamethasone—asthma	2.86e-05	0.0167	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Triamcinolone—asthma	2.79e-05	0.0163	CbGdCrCtD
L-DOPA—Liothyronine—ALB—asthma	2.77e-05	0.0116	CrCbGaD
L-DOPA—SLC7A5—Desoximetasone—Prednisone—asthma	2.65e-05	0.0154	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisolone—asthma	2.59e-05	0.0151	CbGdCrCtD
L-DOPA—Neuropathy peripheral—Prednisone—asthma	2.26e-05	0.000275	CcSEcCtD
L-DOPA—Dizziness—Budesonide—asthma	2.26e-05	0.000275	CcSEcCtD
L-DOPA—Ill-defined disorder—Hydrocortisone—asthma	2.25e-05	0.000274	CcSEcCtD
L-DOPA—Vomiting—Salbutamol—asthma	2.25e-05	0.000273	CcSEcCtD
L-DOPA—Malaise—Prednisolone—asthma	2.24e-05	0.000273	CcSEcCtD
L-DOPA—Dysgeusia—Triamcinolone—asthma	2.24e-05	0.000272	CcSEcCtD
L-DOPA—Rash—Salbutamol—asthma	2.23e-05	0.000271	CcSEcCtD
L-DOPA—Syncope—Prednisolone—asthma	2.23e-05	0.000271	CcSEcCtD
L-DOPA—Dermatitis—Salbutamol—asthma	2.23e-05	0.000271	CcSEcCtD
L-DOPA—Nausea—Formoterol—asthma	2.22e-05	0.000271	CcSEcCtD
L-DOPA—Nausea—Arformoterol—asthma	2.22e-05	0.000271	CcSEcCtD
L-DOPA—Angioedema—Hydrocortisone—asthma	2.22e-05	0.00027	CcSEcCtD
L-DOPA—Headache—Salbutamol—asthma	2.21e-05	0.000269	CcSEcCtD
L-DOPA—Back pain—Triamcinolone—asthma	2.21e-05	0.000269	CcSEcCtD
L-DOPA—Malaise—Hydrocortisone—asthma	2.19e-05	0.000266	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisolone—asthma	2.18e-05	0.000266	CcSEcCtD
L-DOPA—Nausea—Montelukast—asthma	2.18e-05	0.000265	CcSEcCtD
L-DOPA—Vomiting—Budesonide—asthma	2.18e-05	0.000265	CcSEcCtD
L-DOPA—Syncope—Hydrocortisone—asthma	2.17e-05	0.000265	CcSEcCtD
L-DOPA—Rash—Budesonide—asthma	2.16e-05	0.000263	CcSEcCtD
L-DOPA—Dermatitis—Budesonide—asthma	2.16e-05	0.000262	CcSEcCtD
L-DOPA—Convulsion—Prednisolone—asthma	2.15e-05	0.000262	CcSEcCtD
L-DOPA—Headache—Budesonide—asthma	2.14e-05	0.000261	CcSEcCtD
L-DOPA—Hypertension—Prednisolone—asthma	2.14e-05	0.000261	CcSEcCtD
L-DOPA—Loss of consciousness—Hydrocortisone—asthma	2.13e-05	0.000259	CcSEcCtD
L-DOPA—Arrhythmia—Dexamethasone—asthma	2.13e-05	0.000259	CcSEcCtD
L-DOPA—Arrhythmia—Betamethasone—asthma	2.13e-05	0.000259	CcSEcCtD
L-DOPA—Ill-defined disorder—Triamcinolone—asthma	2.12e-05	0.000258	CcSEcCtD
L-DOPA—Ill-defined disorder—Methylprednisolone—asthma	2.11e-05	0.000257	CcSEcCtD
L-DOPA—Alopecia—Betamethasone—asthma	2.1e-05	0.000256	CcSEcCtD
L-DOPA—Alopecia—Dexamethasone—asthma	2.1e-05	0.000256	CcSEcCtD
L-DOPA—Convulsion—Hydrocortisone—asthma	2.1e-05	0.000256	CcSEcCtD
L-DOPA—Nausea—Salbutamol—asthma	2.1e-05	0.000255	CcSEcCtD
L-DOPA—Hypertension—Hydrocortisone—asthma	2.09e-05	0.000255	CcSEcCtD
L-DOPA—Discomfort—Prednisolone—asthma	2.09e-05	0.000254	CcSEcCtD
L-DOPA—Angioedema—Triamcinolone—asthma	2.09e-05	0.000254	CcSEcCtD
L-DOPA—Haemoglobin—Prednisone—asthma	2.08e-05	0.000254	CcSEcCtD
L-DOPA—Angioedema—Methylprednisolone—asthma	2.08e-05	0.000253	CcSEcCtD
L-DOPA—Haemorrhage—Prednisone—asthma	2.07e-05	0.000252	CcSEcCtD
L-DOPA—Hallucination—Prednisone—asthma	2.06e-05	0.000251	CcSEcCtD
L-DOPA—Malaise—Triamcinolone—asthma	2.06e-05	0.000251	CcSEcCtD
L-DOPA—Anxiety—Hydrocortisone—asthma	2.06e-05	0.00025	CcSEcCtD
L-DOPA—Malaise—Methylprednisolone—asthma	2.05e-05	0.00025	CcSEcCtD
L-DOPA—Syncope—Triamcinolone—asthma	2.05e-05	0.000249	CcSEcCtD
L-DOPA—Syncope—Methylprednisolone—asthma	2.04e-05	0.000249	CcSEcCtD
L-DOPA—Discomfort—Hydrocortisone—asthma	2.04e-05	0.000248	CcSEcCtD
L-DOPA—Nausea—Budesonide—asthma	2.03e-05	0.000247	CcSEcCtD
L-DOPA—Oedema—Prednisolone—asthma	2.03e-05	0.000247	CcSEcCtD
L-DOPA—Loss of consciousness—Triamcinolone—asthma	2.01e-05	0.000244	CcSEcCtD
L-DOPA—Loss of consciousness—Methylprednisolone—asthma	2e-05	0.000244	CcSEcCtD
L-DOPA—Shock—Prednisolone—asthma	1.99e-05	0.000243	CcSEcCtD
L-DOPA—Cough—Triamcinolone—asthma	1.99e-05	0.000243	CcSEcCtD
L-DOPA—Oedema—Hydrocortisone—asthma	1.98e-05	0.000241	CcSEcCtD
L-DOPA—Convulsion—Triamcinolone—asthma	1.98e-05	0.000241	CcSEcCtD
L-DOPA—Convulsion—Methylprednisolone—asthma	1.97e-05	0.00024	CcSEcCtD
L-DOPA—Hypertension—Triamcinolone—asthma	1.97e-05	0.00024	CcSEcCtD
L-DOPA—Hypertension—Methylprednisolone—asthma	1.97e-05	0.000239	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisolone—asthma	1.96e-05	0.000238	CcSEcCtD
L-DOPA—Shock—Hydrocortisone—asthma	1.95e-05	0.000237	CcSEcCtD
L-DOPA—Anxiety—Methylprednisolone—asthma	1.93e-05	0.000235	CcSEcCtD
L-DOPA—Flushing—Prednisone—asthma	1.92e-05	0.000234	CcSEcCtD
L-DOPA—Ill-defined disorder—Dexamethasone—asthma	1.92e-05	0.000234	CcSEcCtD
L-DOPA—Ill-defined disorder—Betamethasone—asthma	1.92e-05	0.000234	CcSEcCtD
L-DOPA—Discomfort—Triamcinolone—asthma	1.92e-05	0.000234	CcSEcCtD
L-DOPA—Discomfort—Methylprednisolone—asthma	1.92e-05	0.000233	CcSEcCtD
L-DOPA—Hyperhidrosis—Hydrocortisone—asthma	1.91e-05	0.000233	CcSEcCtD
L-DOPA—Dry mouth—Triamcinolone—asthma	1.9e-05	0.000231	CcSEcCtD
L-DOPA—Angioedema—Betamethasone—asthma	1.89e-05	0.00023	CcSEcCtD
L-DOPA—Angioedema—Dexamethasone—asthma	1.89e-05	0.00023	CcSEcCtD
L-DOPA—Anorexia—Hydrocortisone—asthma	1.89e-05	0.00023	CcSEcCtD
L-DOPA—Confusional state—Methylprednisolone—asthma	1.87e-05	0.000228	CcSEcCtD
L-DOPA—Malaise—Dexamethasone—asthma	1.87e-05	0.000227	CcSEcCtD
L-DOPA—Malaise—Betamethasone—asthma	1.87e-05	0.000227	CcSEcCtD
L-DOPA—Oedema—Triamcinolone—asthma	1.86e-05	0.000227	CcSEcCtD
L-DOPA—Syncope—Dexamethasone—asthma	1.86e-05	0.000226	CcSEcCtD
L-DOPA—Syncope—Betamethasone—asthma	1.86e-05	0.000226	CcSEcCtD
L-DOPA—Arrhythmia—Prednisone—asthma	1.85e-05	0.000225	CcSEcCtD
L-DOPA—Hypotension—Hydrocortisone—asthma	1.85e-05	0.000225	CcSEcCtD
L-DOPA—Shock—Triamcinolone—asthma	1.83e-05	0.000223	CcSEcCtD
L-DOPA—Insomnia—Prednisolone—asthma	1.83e-05	0.000223	CcSEcCtD
L-DOPA—Alopecia—Prednisone—asthma	1.83e-05	0.000223	CcSEcCtD
L-DOPA—Shock—Methylprednisolone—asthma	1.83e-05	0.000223	CcSEcCtD
L-DOPA—Loss of consciousness—Betamethasone—asthma	1.82e-05	0.000222	CcSEcCtD
L-DOPA—Loss of consciousness—Dexamethasone—asthma	1.82e-05	0.000222	CcSEcCtD
L-DOPA—Paraesthesia—Prednisolone—asthma	1.82e-05	0.000221	CcSEcCtD
L-DOPA—Mental disorder—Prednisone—asthma	1.82e-05	0.000221	CcSEcCtD
L-DOPA—Hyperhidrosis—Triamcinolone—asthma	1.8e-05	0.000219	CcSEcCtD
L-DOPA—Hyperhidrosis—Methylprednisolone—asthma	1.8e-05	0.000219	CcSEcCtD
L-DOPA—Convulsion—Dexamethasone—asthma	1.79e-05	0.000218	CcSEcCtD
L-DOPA—Convulsion—Betamethasone—asthma	1.79e-05	0.000218	CcSEcCtD
L-DOPA—Insomnia—Hydrocortisone—asthma	1.79e-05	0.000218	CcSEcCtD
L-DOPA—Hypertension—Dexamethasone—asthma	1.79e-05	0.000218	CcSEcCtD
L-DOPA—Hypertension—Betamethasone—asthma	1.79e-05	0.000218	CcSEcCtD
L-DOPA—Paraesthesia—Hydrocortisone—asthma	1.78e-05	0.000216	CcSEcCtD
L-DOPA—Anxiety—Dexamethasone—asthma	1.76e-05	0.000214	CcSEcCtD
L-DOPA—Anxiety—Betamethasone—asthma	1.76e-05	0.000214	CcSEcCtD
L-DOPA—Discomfort—Betamethasone—asthma	1.74e-05	0.000212	CcSEcCtD
L-DOPA—Discomfort—Dexamethasone—asthma	1.74e-05	0.000212	CcSEcCtD
L-DOPA—Dyspepsia—Hydrocortisone—asthma	1.74e-05	0.000212	CcSEcCtD
L-DOPA—Hypotension—Methylprednisolone—asthma	1.74e-05	0.000211	CcSEcCtD
L-DOPA—Pain—Prednisolone—asthma	1.73e-05	0.000211	CcSEcCtD
L-DOPA—Decreased appetite—Hydrocortisone—asthma	1.72e-05	0.000209	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Hydrocortisone—asthma	1.71e-05	0.000208	CcSEcCtD
L-DOPA—Fatigue—Hydrocortisone—asthma	1.71e-05	0.000208	CcSEcCtD
L-DOPA—Vision blurred—Prednisone—asthma	1.7e-05	0.000207	CcSEcCtD
L-DOPA—Pain—Hydrocortisone—asthma	1.69e-05	0.000206	CcSEcCtD
L-DOPA—Oedema—Betamethasone—asthma	1.69e-05	0.000206	CcSEcCtD
L-DOPA—Oedema—Dexamethasone—asthma	1.69e-05	0.000206	CcSEcCtD
L-DOPA—Insomnia—Triamcinolone—asthma	1.69e-05	0.000205	CcSEcCtD
L-DOPA—Insomnia—Methylprednisolone—asthma	1.68e-05	0.000205	CcSEcCtD
L-DOPA—Ill-defined disorder—Prednisone—asthma	1.67e-05	0.000204	CcSEcCtD
L-DOPA—Paraesthesia—Triamcinolone—asthma	1.67e-05	0.000204	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisolone—asthma	1.67e-05	0.000203	CcSEcCtD
L-DOPA—Paraesthesia—Methylprednisolone—asthma	1.67e-05	0.000203	CcSEcCtD
L-DOPA—Anaemia—Prednisone—asthma	1.67e-05	0.000203	CcSEcCtD
L-DOPA—Shock—Betamethasone—asthma	1.66e-05	0.000202	CcSEcCtD
L-DOPA—Shock—Dexamethasone—asthma	1.66e-05	0.000202	CcSEcCtD
L-DOPA—Dyspnoea—Triamcinolone—asthma	1.66e-05	0.000202	CcSEcCtD
L-DOPA—Agitation—Prednisone—asthma	1.66e-05	0.000202	CcSEcCtD
L-DOPA—Thrombocytopenia—Dexamethasone—asthma	1.66e-05	0.000201	CcSEcCtD
L-DOPA—Thrombocytopenia—Betamethasone—asthma	1.66e-05	0.000201	CcSEcCtD
L-DOPA—Angioedema—Prednisone—asthma	1.65e-05	0.000201	CcSEcCtD
L-DOPA—Dyspepsia—Triamcinolone—asthma	1.64e-05	0.0002	CcSEcCtD
L-DOPA—Dyspepsia—Methylprednisolone—asthma	1.64e-05	0.000199	CcSEcCtD
L-DOPA—Hyperhidrosis—Betamethasone—asthma	1.63e-05	0.000199	CcSEcCtD
L-DOPA—Hyperhidrosis—Dexamethasone—asthma	1.63e-05	0.000199	CcSEcCtD
L-DOPA—Feeling abnormal—Hydrocortisone—asthma	1.63e-05	0.000198	CcSEcCtD
L-DOPA—Malaise—Prednisone—asthma	1.63e-05	0.000198	CcSEcCtD
L-DOPA—Gastrointestinal pain—Hydrocortisone—asthma	1.62e-05	0.000197	CcSEcCtD
L-DOPA—Syncope—Prednisone—asthma	1.62e-05	0.000197	CcSEcCtD
L-DOPA—Anorexia—Betamethasone—asthma	1.61e-05	0.000196	CcSEcCtD
L-DOPA—Anorexia—Dexamethasone—asthma	1.61e-05	0.000196	CcSEcCtD
L-DOPA—Urticaria—Prednisolone—asthma	1.61e-05	0.000196	CcSEcCtD
L-DOPA—Fatigue—Triamcinolone—asthma	1.61e-05	0.000196	CcSEcCtD
L-DOPA—Fatigue—Methylprednisolone—asthma	1.6e-05	0.000195	CcSEcCtD
L-DOPA—Pain—Triamcinolone—asthma	1.59e-05	0.000194	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisone—asthma	1.59e-05	0.000193	CcSEcCtD
L-DOPA—Hypotension—Dexamethasone—asthma	1.58e-05	0.000192	CcSEcCtD
L-DOPA—Hypotension—Betamethasone—asthma	1.58e-05	0.000192	CcSEcCtD
L-DOPA—Urticaria—Hydrocortisone—asthma	1.57e-05	0.000191	CcSEcCtD
L-DOPA—Abdominal pain—Hydrocortisone—asthma	1.56e-05	0.00019	CcSEcCtD
L-DOPA—Convulsion—Prednisone—asthma	1.56e-05	0.00019	CcSEcCtD
L-DOPA—Hypertension—Prednisone—asthma	1.56e-05	0.00019	CcSEcCtD
L-DOPA—Feeling abnormal—Triamcinolone—asthma	1.54e-05	0.000187	CcSEcCtD
L-DOPA—Feeling abnormal—Methylprednisolone—asthma	1.53e-05	0.000186	CcSEcCtD
L-DOPA—Anxiety—Prednisone—asthma	1.53e-05	0.000186	CcSEcCtD
L-DOPA—Insomnia—Dexamethasone—asthma	1.53e-05	0.000186	CcSEcCtD
L-DOPA—Insomnia—Betamethasone—asthma	1.53e-05	0.000186	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methylprednisolone—asthma	1.52e-05	0.000185	CcSEcCtD
L-DOPA—Paraesthesia—Dexamethasone—asthma	1.52e-05	0.000185	CcSEcCtD
L-DOPA—Paraesthesia—Betamethasone—asthma	1.52e-05	0.000185	CcSEcCtD
L-DOPA—Discomfort—Prednisone—asthma	1.52e-05	0.000185	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisolone—asthma	1.49e-05	0.000182	CcSEcCtD
L-DOPA—Dyspepsia—Betamethasone—asthma	1.49e-05	0.000181	CcSEcCtD
L-DOPA—Dyspepsia—Dexamethasone—asthma	1.49e-05	0.000181	CcSEcCtD
L-DOPA—Urticaria—Triamcinolone—asthma	1.48e-05	0.00018	CcSEcCtD
L-DOPA—Urticaria—Methylprednisolone—asthma	1.48e-05	0.00018	CcSEcCtD
L-DOPA—Oedema—Prednisone—asthma	1.47e-05	0.000179	CcSEcCtD
L-DOPA—Abdominal pain—Methylprednisolone—asthma	1.47e-05	0.000179	CcSEcCtD
L-DOPA—Decreased appetite—Dexamethasone—asthma	1.47e-05	0.000179	CcSEcCtD
L-DOPA—Decreased appetite—Betamethasone—asthma	1.47e-05	0.000179	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Betamethasone—asthma	1.46e-05	0.000178	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Dexamethasone—asthma	1.46e-05	0.000178	CcSEcCtD
L-DOPA—Hypersensitivity—Hydrocortisone—asthma	1.46e-05	0.000177	CcSEcCtD
L-DOPA—Fatigue—Betamethasone—asthma	1.46e-05	0.000177	CcSEcCtD
L-DOPA—Fatigue—Dexamethasone—asthma	1.46e-05	0.000177	CcSEcCtD
L-DOPA—Shock—Prednisone—asthma	1.45e-05	0.000176	CcSEcCtD
L-DOPA—Pain—Dexamethasone—asthma	1.45e-05	0.000176	CcSEcCtD
L-DOPA—Pain—Betamethasone—asthma	1.45e-05	0.000176	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisone—asthma	1.42e-05	0.000173	CcSEcCtD
L-DOPA—Asthenia—Hydrocortisone—asthma	1.42e-05	0.000173	CcSEcCtD
L-DOPA—Anorexia—Prednisone—asthma	1.4e-05	0.000171	CcSEcCtD
L-DOPA—Pruritus—Hydrocortisone—asthma	1.4e-05	0.00017	CcSEcCtD
L-DOPA—Feeling abnormal—Dexamethasone—asthma	1.39e-05	0.00017	CcSEcCtD
L-DOPA—Feeling abnormal—Betamethasone—asthma	1.39e-05	0.00017	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dexamethasone—asthma	1.38e-05	0.000168	CcSEcCtD
L-DOPA—Gastrointestinal pain—Betamethasone—asthma	1.38e-05	0.000168	CcSEcCtD
L-DOPA—Hypersensitivity—Triamcinolone—asthma	1.37e-05	0.000167	CcSEcCtD
L-DOPA—Hypersensitivity—Methylprednisolone—asthma	1.37e-05	0.000167	CcSEcCtD
L-DOPA—Diarrhoea—Hydrocortisone—asthma	1.35e-05	0.000165	CcSEcCtD
L-DOPA—Urticaria—Betamethasone—asthma	1.34e-05	0.000163	CcSEcCtD
L-DOPA—Urticaria—Dexamethasone—asthma	1.34e-05	0.000163	CcSEcCtD
L-DOPA—Dizziness—Prednisolone—asthma	1.34e-05	0.000163	CcSEcCtD
L-DOPA—Asthenia—Triamcinolone—asthma	1.34e-05	0.000163	CcSEcCtD
L-DOPA—Abdominal pain—Dexamethasone—asthma	1.34e-05	0.000163	CcSEcCtD
L-DOPA—Abdominal pain—Betamethasone—asthma	1.34e-05	0.000163	CcSEcCtD
L-DOPA—Asthenia—Methylprednisolone—asthma	1.33e-05	0.000162	CcSEcCtD
L-DOPA—Insomnia—Prednisone—asthma	1.33e-05	0.000162	CcSEcCtD
L-DOPA—Paraesthesia—Prednisone—asthma	1.32e-05	0.000161	CcSEcCtD
L-DOPA—Pruritus—Triamcinolone—asthma	1.32e-05	0.00016	CcSEcCtD
L-DOPA—Pruritus—Methylprednisolone—asthma	1.32e-05	0.00016	CcSEcCtD
L-DOPA—Dizziness—Hydrocortisone—asthma	1.31e-05	0.000159	CcSEcCtD
L-DOPA—Dyspepsia—Prednisone—asthma	1.3e-05	0.000158	CcSEcCtD
L-DOPA—Decreased appetite—Prednisone—asthma	1.28e-05	0.000156	CcSEcCtD
L-DOPA—Rash—Prednisolone—asthma	1.28e-05	0.000156	CcSEcCtD
L-DOPA—Dermatitis—Prednisolone—asthma	1.28e-05	0.000155	CcSEcCtD
L-DOPA—Diarrhoea—Methylprednisolone—asthma	1.27e-05	0.000155	CcSEcCtD
L-DOPA—Fatigue—Prednisone—asthma	1.27e-05	0.000155	CcSEcCtD
L-DOPA—Headache—Prednisolone—asthma	1.27e-05	0.000155	CcSEcCtD
L-DOPA—Constipation—Prednisone—asthma	1.26e-05	0.000153	CcSEcCtD
L-DOPA—Vomiting—Hydrocortisone—asthma	1.26e-05	0.000153	CcSEcCtD
L-DOPA—Rash—Hydrocortisone—asthma	1.25e-05	0.000152	CcSEcCtD
L-DOPA—Dermatitis—Hydrocortisone—asthma	1.25e-05	0.000152	CcSEcCtD
L-DOPA—Headache—Hydrocortisone—asthma	1.24e-05	0.000151	CcSEcCtD
L-DOPA—Dizziness—Triamcinolone—asthma	1.23e-05	0.00015	CcSEcCtD
L-DOPA—Dizziness—Methylprednisolone—asthma	1.23e-05	0.00015	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisone—asthma	1.21e-05	0.000148	CcSEcCtD
L-DOPA—Asthenia—Betamethasone—asthma	1.21e-05	0.000148	CcSEcCtD
L-DOPA—Asthenia—Dexamethasone—asthma	1.21e-05	0.000148	CcSEcCtD
L-DOPA—Gastrointestinal pain—Prednisone—asthma	1.2e-05	0.000147	CcSEcCtD
L-DOPA—Nausea—Prednisolone—asthma	1.2e-05	0.000146	CcSEcCtD
L-DOPA—Pruritus—Betamethasone—asthma	1.2e-05	0.000146	CcSEcCtD
L-DOPA—Pruritus—Dexamethasone—asthma	1.2e-05	0.000146	CcSEcCtD
L-DOPA—Vomiting—Triamcinolone—asthma	1.18e-05	0.000144	CcSEcCtD
L-DOPA—Vomiting—Methylprednisolone—asthma	1.18e-05	0.000144	CcSEcCtD
L-DOPA—Nausea—Hydrocortisone—asthma	1.18e-05	0.000143	CcSEcCtD
L-DOPA—Rash—Triamcinolone—asthma	1.17e-05	0.000143	CcSEcCtD
L-DOPA—Dermatitis—Triamcinolone—asthma	1.17e-05	0.000143	CcSEcCtD
L-DOPA—Rash—Methylprednisolone—asthma	1.17e-05	0.000143	CcSEcCtD
L-DOPA—Dermatitis—Methylprednisolone—asthma	1.17e-05	0.000143	CcSEcCtD
L-DOPA—Urticaria—Prednisone—asthma	1.17e-05	0.000142	CcSEcCtD
L-DOPA—Headache—Triamcinolone—asthma	1.17e-05	0.000142	CcSEcCtD
L-DOPA—Headache—Methylprednisolone—asthma	1.16e-05	0.000142	CcSEcCtD
L-DOPA—Abdominal pain—Prednisone—asthma	1.16e-05	0.000142	CcSEcCtD
L-DOPA—Diarrhoea—Betamethasone—asthma	1.16e-05	0.000141	CcSEcCtD
L-DOPA—Diarrhoea—Dexamethasone—asthma	1.16e-05	0.000141	CcSEcCtD
L-DOPA—Dizziness—Dexamethasone—asthma	1.12e-05	0.000136	CcSEcCtD
L-DOPA—Dizziness—Betamethasone—asthma	1.12e-05	0.000136	CcSEcCtD
L-DOPA—Nausea—Triamcinolone—asthma	1.11e-05	0.000135	CcSEcCtD
L-DOPA—Nausea—Methylprednisolone—asthma	1.1e-05	0.000134	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisone—asthma	1.08e-05	0.000132	CcSEcCtD
L-DOPA—Vomiting—Dexamethasone—asthma	1.07e-05	0.000131	CcSEcCtD
L-DOPA—Vomiting—Betamethasone—asthma	1.07e-05	0.000131	CcSEcCtD
L-DOPA—Rash—Dexamethasone—asthma	1.07e-05	0.00013	CcSEcCtD
L-DOPA—Rash—Betamethasone—asthma	1.07e-05	0.00013	CcSEcCtD
L-DOPA—Dermatitis—Dexamethasone—asthma	1.06e-05	0.00013	CcSEcCtD
L-DOPA—Dermatitis—Betamethasone—asthma	1.06e-05	0.00013	CcSEcCtD
L-DOPA—Headache—Dexamethasone—asthma	1.06e-05	0.000129	CcSEcCtD
L-DOPA—Headache—Betamethasone—asthma	1.06e-05	0.000129	CcSEcCtD
L-DOPA—Asthenia—Prednisone—asthma	1.06e-05	0.000129	CcSEcCtD
L-DOPA—Pruritus—Prednisone—asthma	1.04e-05	0.000127	CcSEcCtD
L-DOPA—Diarrhoea—Prednisone—asthma	1.01e-05	0.000123	CcSEcCtD
L-DOPA—Nausea—Dexamethasone—asthma	1e-05	0.000122	CcSEcCtD
L-DOPA—Nausea—Betamethasone—asthma	1e-05	0.000122	CcSEcCtD
L-DOPA—Dizziness—Prednisone—asthma	9.74e-06	0.000119	CcSEcCtD
L-DOPA—Vomiting—Prednisone—asthma	9.36e-06	0.000114	CcSEcCtD
L-DOPA—Rash—Prednisone—asthma	9.28e-06	0.000113	CcSEcCtD
L-DOPA—Dermatitis—Prednisone—asthma	9.27e-06	0.000113	CcSEcCtD
L-DOPA—Headache—Prednisone—asthma	9.22e-06	0.000112	CcSEcCtD
L-DOPA—Nausea—Prednisone—asthma	8.74e-06	0.000106	CcSEcCtD
L-DOPA—DRD3—GPCR downstream signaling—POMC—asthma	4.09e-06	0.000106	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6R—asthma	4.08e-06	0.000106	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL10—asthma	4.07e-06	0.000106	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PDGFB—asthma	4.07e-06	0.000106	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—EDN1—asthma	4.07e-06	0.000105	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTGS2—asthma	4.06e-06	0.000105	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—RHOA—asthma	4.06e-06	0.000105	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL5—asthma	4.04e-06	0.000105	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PLA2G4A—asthma	4.02e-06	0.000104	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADCY2—asthma	4.02e-06	0.000104	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCR5—asthma	4e-06	0.000104	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL3—asthma	4e-06	0.000104	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NTRK1—asthma	4e-06	0.000104	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CSF2—asthma	3.97e-06	0.000103	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADCY2—asthma	3.96e-06	0.000103	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADRB2—asthma	3.96e-06	0.000103	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL3—asthma	3.95e-06	0.000102	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2RA—asthma	3.95e-06	0.000102	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR3—asthma	3.92e-06	0.000102	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—C3—asthma	3.91e-06	0.000101	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—LEP—asthma	3.89e-06	0.000101	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NPY—asthma	3.82e-06	9.9e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—KNG1—asthma	3.78e-06	9.79e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—POMC—asthma	3.76e-06	9.75e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—AGTR1—asthma	3.75e-06	9.73e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ITPR1—asthma	3.74e-06	9.7e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—KNG1—asthma	3.73e-06	9.66e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—POMC—asthma	3.71e-06	9.62e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AGTR1—asthma	3.7e-06	9.6e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PPP2CA—asthma	3.7e-06	9.6e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AGTR2—asthma	3.69e-06	9.55e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—RHOA—asthma	3.68e-06	9.55e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCL2—asthma	3.68e-06	9.54e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FN1—asthma	3.67e-06	9.52e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6R—asthma	3.67e-06	9.52e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL10—asthma	3.67e-06	9.51e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—RHOA—asthma	3.65e-06	9.47e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCR5—asthma	3.64e-06	9.42e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCL2—asthma	3.63e-06	9.42e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6R—asthma	3.62e-06	9.39e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL10—asthma	3.62e-06	9.38e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—RHOA—asthma	3.6e-06	9.34e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NTRK1—asthma	3.6e-06	9.33e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2RA—asthma	3.58e-06	9.29e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CD86—asthma	3.56e-06	9.23e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CXCL8—asthma	3.56e-06	9.23e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADRB2—asthma	3.56e-06	9.23e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—C3—asthma	3.55e-06	9.21e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NTRK1—asthma	3.55e-06	9.2e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTEN—asthma	3.54e-06	9.18e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EDN1—asthma	3.53e-06	9.16e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EDNRB—asthma	3.53e-06	9.15e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALOX15—asthma	3.52e-06	9.11e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALOX5AP—asthma	3.52e-06	9.11e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADRB2—asthma	3.51e-06	9.11e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL5—asthma	3.51e-06	9.09e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PLA2G4A—asthma	3.49e-06	9.06e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TAC1—asthma	3.49e-06	9.06e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NPS—asthma	3.49e-06	9.06e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CSF2—asthma	3.45e-06	8.95e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCR3—asthma	3.43e-06	8.88e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2—asthma	3.4e-06	8.82e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ITPR1—asthma	3.37e-06	8.73e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SMAD3—asthma	3.36e-06	8.72e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CHAT—asthma	3.35e-06	8.69e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—POMC—asthma	3.35e-06	8.67e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ITPR1—asthma	3.32e-06	8.61e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CYBA—asthma	3.32e-06	8.6e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—RHOA—asthma	3.32e-06	8.6e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCL2—asthma	3.27e-06	8.49e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—RHOA—asthma	3.27e-06	8.48e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6R—asthma	3.26e-06	8.46e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PARP1—asthma	3.25e-06	8.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL5—asthma	3.25e-06	8.42e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL8—asthma	3.23e-06	8.38e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PPP2CA—asthma	3.22e-06	8.34e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CD86—asthma	3.21e-06	8.31e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL8—asthma	3.21e-06	8.31e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—EGFR—asthma	3.2e-06	8.3e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EDN1—asthma	3.18e-06	8.25e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CD86—asthma	3.16e-06	8.2e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL8—asthma	3.16e-06	8.2e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCR5—asthma	3.16e-06	8.19e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL5—asthma	3.16e-06	8.18e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PLA2G4A—asthma	3.15e-06	8.15e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EDN1—asthma	3.14e-06	8.14e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—BDKRB2—asthma	3.13e-06	8.12e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—POMC—asthma	3.13e-06	8.11e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL5—asthma	3.12e-06	8.08e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2RA—asthma	3.11e-06	8.07e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CSF2—asthma	3.11e-06	8.06e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PLA2G4A—asthma	3.1e-06	8.04e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2—asthma	3.09e-06	8.01e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—C3—asthma	3.09e-06	8e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CSF2—asthma	3.07e-06	7.95e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2—asthma	3.06e-06	7.94e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SERPINE1—asthma	3.06e-06	7.92e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADCY2—asthma	3.03e-06	7.86e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SMAD3—asthma	3.03e-06	7.85e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2—asthma	3.02e-06	7.84e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL3—asthma	3.02e-06	7.83e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PDGFB—asthma	3.01e-06	7.79e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALOX5—asthma	2.99e-06	7.75e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SMAD3—asthma	2.99e-06	7.74e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—RHOA—asthma	2.95e-06	7.64e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NOS3—asthma	2.92e-06	7.56e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL8—asthma	2.91e-06	7.55e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PPP2CA—asthma	2.9e-06	7.51e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—LEP—asthma	2.87e-06	7.45e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL8—asthma	2.87e-06	7.45e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PPP2CA—asthma	2.86e-06	7.41e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CARM1—asthma	2.85e-06	7.39e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—KNG1—asthma	2.85e-06	7.39e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCR5—asthma	2.84e-06	7.37e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—POMC—asthma	2.84e-06	7.36e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AGTR1—asthma	2.83e-06	7.35e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DCN—asthma	2.81e-06	7.29e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCR5—asthma	2.81e-06	7.27e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2RA—asthma	2.8e-06	7.27e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2—asthma	2.78e-06	7.21e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL2—asthma	2.78e-06	7.21e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—C3—asthma	2.78e-06	7.21e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6R—asthma	2.77e-06	7.18e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL10—asthma	2.77e-06	7.18e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2RA—asthma	2.77e-06	7.17e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—RHOA—asthma	2.76e-06	7.15e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2—asthma	2.74e-06	7.12e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—C3—asthma	2.74e-06	7.11e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALDH2—asthma	2.73e-06	7.09e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NTRK1—asthma	2.72e-06	7.04e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FN1—asthma	2.71e-06	7.03e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PDGFB—asthma	2.71e-06	7.01e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADRB2—asthma	2.69e-06	6.97e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PDGFB—asthma	2.67e-06	6.92e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTT1—asthma	2.6e-06	6.74e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL8—asthma	2.59e-06	6.71e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LEP—asthma	2.59e-06	6.71e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LEP—asthma	2.55e-06	6.62e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ITPR1—asthma	2.54e-06	6.59e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—RHOA—asthma	2.5e-06	6.49e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2—asthma	2.47e-06	6.41e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—POMC—asthma	2.47e-06	6.4e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—asthma	2.46e-06	6.38e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FN1—asthma	2.44e-06	6.33e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CD86—asthma	2.42e-06	6.28e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL8—asthma	2.42e-06	6.27e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL2—asthma	2.42e-06	6.26e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6R—asthma	2.41e-06	6.24e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FN1—asthma	2.41e-06	6.24e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EDN1—asthma	2.4e-06	6.23e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL5—asthma	2.38e-06	6.18e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PLA2G4A—asthma	2.37e-06	6.16e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—EGFR—asthma	2.36e-06	6.13e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CSF2—asthma	2.35e-06	6.09e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MMP9—asthma	2.34e-06	6.07e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTEN—asthma	2.33e-06	6.03e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2—asthma	2.31e-06	6e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SMAD3—asthma	2.29e-06	5.93e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SERPINE1—asthma	2.26e-06	5.85e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—POMC—asthma	2.22e-06	5.76e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL8—asthma	2.2e-06	5.7e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—POMC—asthma	2.19e-06	5.69e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PPP2CA—asthma	2.19e-06	5.67e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RHOA—asthma	2.18e-06	5.64e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL2—asthma	2.18e-06	5.64e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6R—asthma	2.17e-06	5.62e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NQO1—asthma	2.16e-06	5.6e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOS3—asthma	2.15e-06	5.58e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR5—asthma	2.15e-06	5.57e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL2—asthma	2.15e-06	5.56e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6R—asthma	2.14e-06	5.55e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—EGFR—asthma	2.13e-06	5.52e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2RA—asthma	2.12e-06	5.49e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADCY2—asthma	2.12e-06	5.48e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—VEGFA—asthma	2.1e-06	5.45e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2—asthma	2.1e-06	5.44e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—EGFR—asthma	2.1e-06	5.44e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—C3—asthma	2.1e-06	5.44e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—STAT3—asthma	2.08e-06	5.4e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PDGFB—asthma	2.04e-06	5.29e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SERPINE1—asthma	2.03e-06	5.26e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SERPINE1—asthma	2e-06	5.19e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RHOA—asthma	1.96e-06	5.08e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LEP—asthma	1.95e-06	5.06e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOS3—asthma	1.94e-06	5.03e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RHOA—asthma	1.93e-06	5.01e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TGFB1—asthma	1.93e-06	5e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOS3—asthma	1.91e-06	4.96e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL8—asthma	1.91e-06	4.95e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EGFR—asthma	1.89e-06	4.9e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FN1—asthma	1.84e-06	4.78e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2—asthma	1.83e-06	4.73e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—asthma	1.82e-06	4.71e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTP1—asthma	1.8e-06	4.67e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—HMOX1—asthma	1.78e-06	4.61e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ITPR1—asthma	1.77e-06	4.6e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CAT—asthma	1.75e-06	4.55e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP9—asthma	1.73e-06	4.48e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL8—asthma	1.72e-06	4.46e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTEN—asthma	1.72e-06	4.45e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL8—asthma	1.7e-06	4.4e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—POMC—asthma	1.68e-06	4.35e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTM1—asthma	1.66e-06	4.29e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PLA2G4A—asthma	1.66e-06	4.29e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2—asthma	1.64e-06	4.26e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL2—asthma	1.64e-06	4.26e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6R—asthma	1.64e-06	4.24e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—asthma	1.64e-06	4.24e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2—asthma	1.62e-06	4.2e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—asthma	1.61e-06	4.18e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—EGFR—asthma	1.61e-06	4.16e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP9—asthma	1.56e-06	4.03e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—VEGFA—asthma	1.55e-06	4.02e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTEN—asthma	1.55e-06	4.01e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—STAT3—asthma	1.54e-06	3.98e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP9—asthma	1.53e-06	3.98e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SERPINE1—asthma	1.53e-06	3.97e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTEN—asthma	1.53e-06	3.95e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PPP2CA—asthma	1.53e-06	3.95e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RHOA—asthma	1.48e-06	3.83e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOS3—asthma	1.46e-06	3.79e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—asthma	1.45e-06	3.77e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TGFB1—asthma	1.42e-06	3.69e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—VEGFA—asthma	1.4e-06	3.62e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EGFR—asthma	1.4e-06	3.62e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—STAT3—asthma	1.38e-06	3.58e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—VEGFA—asthma	1.38e-06	3.57e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—STAT3—asthma	1.36e-06	3.54e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL8—asthma	1.3e-06	3.37e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TGFB1—asthma	1.28e-06	3.32e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TGFB1—asthma	1.26e-06	3.28e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EGFR—asthma	1.26e-06	3.26e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2—asthma	1.24e-06	3.22e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EGFR—asthma	1.24e-06	3.21e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—asthma	1.23e-06	3.2e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP9—asthma	1.17e-06	3.04e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—POMC—asthma	1.17e-06	3.04e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTEN—asthma	1.17e-06	3.03e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—asthma	1.07e-06	2.78e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALB—asthma	1.07e-06	2.77e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—VEGFA—asthma	1.05e-06	2.73e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—STAT3—asthma	1.04e-06	2.71e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NOS3—asthma	1.02e-06	2.65e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFB1—asthma	9.68e-07	2.51e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—asthma	9.66e-07	2.5e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—asthma	9.53e-07	2.47e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EGFR—asthma	9.49e-07	2.46e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS2—asthma	9.34e-07	2.42e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTEN—asthma	8.14e-07	2.11e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—asthma	7.29e-07	1.89e-05	CbGpPWpGaD
